Business Wire

AL-ADTRAN

5.12.2023 14:01:36 CET | Business Wire | Press release

Share
Adtran’s Mosaic One simplifies network operations for over 300 new customers

Adtran today celebrated adding over 300 new Mosaic One customers in under 18 months. The rapid adoption of Adtran’s cloud-based software-as-a-service (SaaS) platform highlights its ability to address the demands of modern broadband networks. Mosaic One optimizes network operations by utilizing advanced AI-driven algorithms to anticipate and resolve issues before they impact performance. Its three dedicated portals - Care, Operate and Promote – enable service providers to manage complex deployments, reduce costs and deliver superior services to their subscribers. What’s more, Mosaic One is vendor- and technology-neutral, providing an all-encompassing monitoring solution for FTTH, DOCSIS, DSL and fixed wireless networks across multiple vendors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231205627594/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Adtran’s Mosaic One helps service providers maximize the value of their fiber networks. (Photo: Business Wire)

“DFN’s partnership with Adtran and Mosaic One delivers real-time data and insights for our network and customer service teams, allowing us to care for our customers and fiber network proactively and efficiently,” said Todd Way, CEO of DFN. “The Mosaic Marketing Center has also been a considerable time and cost saver for DFN. Our marketing manager can quickly execute and customize community-centered campaigns with the click of a few buttons. Mosaic One positively impacts our operations, our employees and our customers.”

Mosaic One is a vendor- and technology-agnostic solution designed to adapt to the evolving needs of both service providers and end-users. With its predictive insights, real-time monitoring and intuitive user interface, it provides new opportunities and alleviates the workload for support teams, network engineers and marketers. It’s also recently been enhanced with several new features and capabilities. These include Intellifi®, Adtran’s cloud-managed Wi-Fi solution. This provides service providers with unprecedented control over the home Wi-Fi experience, maximizing customer satisfaction, loyalty and spend.

Additionally, the newly introduced Mosaic Marketing Center is a comprehensive marketing platform, offering professionally produced promotional materials, including videos, animated explainers and local stock photography to amplify campaigns. It features an instant customization tool, enabling swift branding and deployment of content, ensuring service providers can quickly tailor and launch their marketing initiatives. Also integrated into the platform is the Fiber Gaming Network, a fully managed turnkey solution for esports management, presenting fresh avenues for revenue growth.

“In less than 18 months, Mosaic One has hit a huge milestone. We often talk about how it empowers service providers to maximize the value of fiber networks. But Mosaic One’s success is also due to the fact that it gives customers what they need — a service with no hidden fees and no additional charges post-deployment. Many of our new customers came to us drained by the intricate licensing and perplexing invoicing their prior vendors used. Instead, what you get with Mosaic One is one invoice, one service, one incredibly easy way to manage your entire network,” commented Robert Conger, GM of software platforms at Adtran. “Achieving 300 deployments in such a short period is impressive, but for Mosaic One, it’s just the beginning. With more service-enhancing and revenue-boosting features in the pipeline, we’ll help shape a new era of opportunity for service providers.”

About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

Published by
ADTRAN Holdings, Inc.
www.adtran.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231205627594/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release

Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar

ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release

First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno

BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release

Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures

IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release

IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi

Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye